These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 21564281)

  • 1. Longitudinal left ventricular strain in hypertrophic cardiomyopathy: correlation with nonsustained ventricular tachycardia.
    Correia E; Rodrigues B; Santos LF; Moreira D; Gama P; Cabral C; Santos O
    Echocardiography; 2011 Aug; 28(7):709-14. PubMed ID: 21564281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non sustained ventricular tachycardia in hypertrophic cardiomyopathy and new ultrasonic derived parameters.
    Di Salvo G; Pacileo G; Limongelli G; Baldini L; Rea A; Verrengia M; D'Andrea A; Russo MG; Calabrò R
    J Am Soc Echocardiogr; 2010 Jun; 23(6):581-90. PubMed ID: 20362415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between the quantitative extent of late gadolinium enhancement and burden of nonsustained ventricular tachycardia in hypertrophic cardiomyopathy: A delayed contrast-enhanced magnetic resonance study.
    Weissler-Snir A; Hindieh W; Spears DA; Adler A; Rakowski H; Chan RH
    J Cardiovasc Electrophysiol; 2019 May; 30(5):651-657. PubMed ID: 30680853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left ventricular mechanical dispersion is associated with nonsustained ventricular tachycardia in hypertrophic cardiomyopathy.
    Jalanko M; Tarkiainen M; Sipola P; Jääskeläinen P; Lauerma K; Laine M; Nieminen MS; Laakso M; Heliö T; Kuusisto J
    Ann Med; 2016 Sep; 48(6):417-427. PubMed ID: 27249556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left ventricular twist in hypertrophic cardiomyopathy : Predictor of nonsustained ventricular tachycardia.
    Candan O; Gecmen C; Kalaycı A; Bayam E; Guner A; Gunduz S; Cersit S; Ozkan M
    Herz; 2019 May; 44(3):238-246. PubMed ID: 29038823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left ventricular and atrial functions in hypertrophic cardiomyopathy patients with very high LVOT gradient: a speckle tracking echocardiographic study.
    Tigen K; Sunbul M; Karaahmet T; Dundar C; Ozben B; Guler A; Cincin A; Bulut M; Sari I; Basaran Y
    Echocardiography; 2014 Aug; 31(7):833-41. PubMed ID: 24341920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffuse Ventricular Fibrosis on Cardiac Magnetic Resonance Imaging Associates With Ventricular Tachycardia in Patients With Hypertrophic Cardiomyopathy.
    McLELLAN AJ; Ellims AH; Prabhu S; Voskoboinik A; Iles LM; Hare JL; Kaye DM; Macciocca I; Mariani JA; Kalman JM; Taylor AJ; Kistler PM
    J Cardiovasc Electrophysiol; 2016 May; 27(5):571-80. PubMed ID: 26840595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of left ventricular systolic and diastolic abnormalities in patients with hypertrophic cardiomyopathy using real-time three-dimensional echocardiography and two-dimensional speckle tracking imaging.
    Huang X; Yue Y; Wang Y; Deng Y; Liu L; Di Y; Sun S; Chen D; Fan L; Cao J
    Cardiovasc Ultrasound; 2018 Oct; 16(1):23. PubMed ID: 30285887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systolic function reserve using two-dimensional strain imaging in hypertrophic cardiomyopathy: comparison with essential hypertension.
    Badran HM; Faheem N; Ibrahim WA; Elnoamany MF; Elsedi M; Yacoub M
    J Am Soc Echocardiogr; 2013 Dec; 26(12):1397-406. PubMed ID: 24094559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients.
    Monserrat L; Elliott PM; Gimeno JR; Sharma S; Penas-Lado M; McKenna WJ
    J Am Coll Cardiol; 2003 Sep; 42(5):873-9. PubMed ID: 12957435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid Device-Detected Nonsustained Ventricular Tachycardia in the Risk Stratification of Hypertrophic Cardiomyopathy.
    Viswanathan K; Suszko AM; DAS M; Jackson N; Gollob M; Cameron D; Spears D; Woo A; Rakowski H; Khurana M; Chauhan VS
    Pacing Clin Electrophysiol; 2016 Jul; 39(7):642-51. PubMed ID: 27027856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early changes in apical rotation in genotype positive children with hypertrophic cardiomyopathy mutations without hypertrophic changes on two-dimensional imaging.
    Forsey J; Benson L; Rozenblyum E; Friedberg MK; Mertens L
    J Am Soc Echocardiogr; 2014 Feb; 27(2):215-21. PubMed ID: 24325958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late hyperenhancement in gadolinium-enhanced magnetic resonance imaging: comparison of hypertrophic cardiomyopathy patients with and without nonsustained ventricular tachycardia.
    Dimitrow PP; Klimeczek P; Vliegenthart R; Pasowicz M; Oudkerk M; Podolec P; Tracz W; Dubiel JS
    Int J Cardiovasc Imaging; 2008 Jan; 24(1):77-83; discussion 85-7. PubMed ID: 17624806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial ultrasound tissue characterization in patients with hypertrophic cardiomyopathy: noninvasive evidence of electrical and textural substrate for ventricular arrhythmias.
    Limongelli G; Pacileo G; Cerrato F; Verrengia M; Di Simone A; Severino S; Sarubbi B; Calabrò R
    J Am Soc Echocardiogr; 2003 Aug; 16(8):803-7. PubMed ID: 12878988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between intraventricular myocardial systolic dyssynchrony and ventricular arrhythmias in patients with hypertrophic cardiomyopathy.
    D'Andrea A; Caso P; Severino S; Scotto di Uccio F; Vigorito F; Ascione L; Scherillo M; Calabrò R
    Echocardiography; 2005 Aug; 22(7):571-8. PubMed ID: 16060893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlations between cardiac troponin I and nonsustained ventricular tachycardia in hypertrophic obstructive cardiomyopathy.
    Liu L; Liu S; Shen L; Tu B; Hu Z; Hu F; Zheng L; Ding L; Fan X; Yao Y
    Clin Cardiol; 2020 Oct; 43(10):1150-1159. PubMed ID: 32810305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical impact of nonsustained ventricular tachycardia recorded by the implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy.
    Francia P; Santini D; Musumeci B; Semprini L; Adduci C; Pagannone E; Proietti G; Volpe M; Autore C
    J Cardiovasc Electrophysiol; 2014 Nov; 25(11):1180-7. PubMed ID: 25066044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High signal intensity on T2-weighted cardiac magnetic resonance imaging correlates with the ventricular tachyarrhythmia in hypertrophic cardiomyopathy.
    Hen Y; Iguchi N; Machida H; Takada K; Utanohara Y; Sumiyoshi T
    Heart Vessels; 2013 Nov; 28(6):742-9. PubMed ID: 23097076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of global and regional myocardial mechanics with 3-dimensional speckle tracking echocardiography and relations to hypertrophy and fibrosis in hypertrophic cardiomyopathy.
    Urbano-Moral JA; Rowin EJ; Maron MS; Crean A; Pandian NG
    Circ Cardiovasc Imaging; 2014 Jan; 7(1):11-9. PubMed ID: 24275954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of 14-Day Holter for Detection of Nonsustained Ventricular Tachycardia in Patients With Hypertrophic Cardiomyopathy.
    Weissler-Snir A; Chan RH; Adler A; Care M; Chauhan V; Gollob MH; Ziv-Baran T; Fourey D; Hindieh W; Rakowski H; Spears DA
    Am J Cardiol; 2016 Oct; 118(8):1258-1263. PubMed ID: 27567133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.